Latest Convertible Notes News

Page 12 of 68
RBR Group Limited narrowed its half-year loss to $588,746 as Mozambique LNG project activities resumed, underpinning cautious optimism amid ongoing funding challenges.
Maxwell Dee
Maxwell Dee
27 Feb 2026
Halo Technologies Holdings Ltd posted a $17.4 million loss for 2025, widening from $14.5 million the previous year, as revenue fell 16%. The company completed a $3.9 million rights issue and announced a strategic pivot in its UK operations.
Claire Turing
Claire Turing
27 Feb 2026
I Synergy Group Limited reported a 15.63% drop in revenue to AUD 0.81 million for FY2025, alongside a 21.5% increase in net loss to AUD 0.34 million, with auditors flagging going concern uncertainties.
Sophie Babbage
Sophie Babbage
27 Feb 2026
CONNEQT Health reported a 40% revenue increase to $2.28 million for the half-year ending December 2025, driven by strong sales of its CONNEQT Pulse device and early subscription uptake. Despite narrowing its net loss by 14%, the company continues to navigate operational restructuring and funding challenges as it pivots towards a recurring revenue model.
Ada Torres
Ada Torres
27 Feb 2026
Energy Technologies Limited reported a $5.63 million net loss for the half-year ending December 2025, with revenue down 53% as the company restructures and refocuses on renewable energy markets. Significant debt refinancing and board changes mark a critical phase for the industrial cable manufacturer.
Victor Sage
Victor Sage
27 Feb 2026
Memphasys Limited has advanced its Felix™ System commercial rollout with key regulatory approvals and new international contracts, while trimming operating costs and narrowing losses in the first half of FY2026.
Ada Torres
Ada Torres
27 Feb 2026
Hydrix Limited reported a 14% revenue decline and a sharp increase in net loss for H1 2026, raising concerns about its financial stability despite securing a major contract.
Ada Torres
Ada Torres
27 Feb 2026
X2M Connect Limited has secured a $3 million capital raise to fund expansion into new markets and reduce debt, following a robust first half of FY26 marked by significant revenue and profit growth.
Sophie Babbage
Sophie Babbage
27 Feb 2026
Paradigm Biopharmaceuticals reports a sharp rise in half-year losses as it intensifies investment in its pivotal Phase 3 trial for knee osteoarthritis, setting sights on a critical interim analysis in mid-2026. The company also expands its osteoarthritis pipeline and maintains strong funding amid a strengthening biotech sector.
Ada Torres
Ada Torres
27 Feb 2026
Matrix Composites & Engineering Ltd reported a $9.4 million loss for the half-year ending December 2025, driven by a 32% drop in revenue to $26.9 million. Despite the weak first half, the company anticipates a robust second half to meet or exceed last year’s full-year revenue.
Victor Sage
Victor Sage
27 Feb 2026
Harvest Technology Group’s half-year report reveals a 50% revenue decline and a widening net loss, offset by a $6 million funding facility and strategic partnerships.
Sophie Babbage
Sophie Babbage
27 Feb 2026
ARC Funds Limited posted a $1 million loss for the half-year ending December 2025, while significantly increasing revenues and expanding its ownership in The Term Deposit Shop to 74.48%. The company raised nearly $1.9 million to support growth initiatives amid ongoing operational challenges.
Claire Turing
Claire Turing
27 Feb 2026